These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31869742)

  • 21. The expression of congenital Shoc2 variants induces AKT-dependent crosstalk activation of the ERK1/2 pathway.
    Wilson PG; Abdelmoti L; Gao T; Galperin E
    Hum Mol Genet; 2024 Sep; 33(18):1592-1604. PubMed ID: 38881369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of congenital Shoc2 variants induces AKT-dependent feedback activation of the ERK1/2 pathway.
    Wilson P; Abdelmoti L; Gao T; Galperin E
    bioRxiv; 2023 Dec; ():. PubMed ID: 38187642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematopoietic and neural crest defects in zebrafish shoc2 mutants: a novel vertebrate model for Noonan-like syndrome.
    Jang H; Oakley E; Forbes-Osborne M; Kesler MV; Norcross R; Morris AC; Galperin E
    Hum Mol Genet; 2019 Feb; 28(3):501-514. PubMed ID: 30329053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complex.
    Kwon JJ; Hajian B; Bian Y; Young LC; Amor AJ; Fuller JR; Fraley CV; Sykes AM; So J; Pan J; Baker L; Lee SJ; Wheeler DB; Mayhew DL; Persky NS; Yang X; Root DE; Barsotti AM; Stamford AW; Perry CK; Burgin A; McCormick F; Lemke CT; Hahn WC; Aguirre AJ
    Nature; 2022 Sep; 609(7926):408-415. PubMed ID: 35831509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers.
    Sulahian R; Kwon JJ; Walsh KH; Pailler E; Bosse TL; Thaker M; Almanza D; Dempster JM; Pan J; Piccioni F; Dumont N; Gonzalez A; Rennhack J; Nabet B; Bachman JA; Goodale A; Lee Y; Bagul M; Liao R; Navarro A; Yuan TL; Ng RWS; Raghavan S; Gray NS; Tsherniak A; Vazquez F; Root DE; Firestone AJ; Settleman J; Hahn WC; Aguirre AJ
    Cell Rep; 2019 Oct; 29(1):118-134.e8. PubMed ID: 31577942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
    Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
    Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The leucine-rich repeat signaling scaffolds Shoc2 and Erbin: cellular mechanism and role in disease.
    Jang H; Stevens P; Gao T; Galperin E
    FEBS J; 2021 Feb; 288(3):721-739. PubMed ID: 32558243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MTORC1-mediated autophagy is regulated by the FBXW7-SHOC2-RPTOR axis.
    Xie CM; Sun Y
    Autophagy; 2019 Aug; 15(8):1470-1472. PubMed ID: 31010381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies.
    Moutel S; Bery N; Bernard V; Keller L; Lemesre E; de Marco A; Ligat L; Rain JC; Favre G; Olichon A; Perez F
    Elife; 2016 Jul; 5():. PubMed ID: 27434673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding the molecular spectrum of pathogenic SHOC2 variants underlying Mazzanti syndrome.
    Motta M; Solman M; Bonnard AA; Kuechler A; Pantaleoni F; Priolo M; Chandramouli B; Coppola S; Pizzi S; Zara E; Ferilli M; Kayserili H; Onesimo R; Leoni C; Brinkmann J; Vial Y; Kamphausen SB; Thomas-Teinturier C; Guimier A; Cordeddu V; Mazzanti L; Zampino G; Chillemi G; Zenker M; Cavé H; den Hertog J; Tartaglia M
    Hum Mol Genet; 2022 Aug; 31(16):2766-2778. PubMed ID: 35348676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sur8/Shoc2 involves both inhibition of differentiation and maintenance of self-renewal of neural progenitor cells via modulation of extracellular signal-regulated kinase signaling.
    Moon BS; Kim HY; Kim MY; Yang DH; Lee JM; Cho KW; Jung HS; Choi KY
    Stem Cells; 2011 Feb; 29(2):320-31. PubMed ID: 21732489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-Domain Antibodies or Nanobodies: A Class of Next-Generation Antibodies.
    Khodabakhsh F; Behdani M; Rami A; Kazemi-Lomedasht F
    Int Rev Immunol; 2018; 37(6):316-322. PubMed ID: 30741045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Camelid single-domain antibodies raised by DNA immunization are potent inhibitors of EGFR signaling.
    Rossotti MA; Henry KA; van Faassen H; Tanha J; Callaghan D; Hussack G; Arbabi-Ghahroudi M; MacKenzie CR
    Biochem J; 2019 Jan; 476(1):39-50. PubMed ID: 30455372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VCA nanobodies target N-WASp to reduce invadopodium formation and functioning.
    Hebbrecht T; Van Audenhove I; Zwaenepoel O; Verhelle A; Gettemans J
    PLoS One; 2017; 12(9):e0185076. PubMed ID: 28938008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circumvention of common labelling artefacts using secondary nanobodies.
    Sograte-Idrissi S; Schlichthaerle T; Duque-Afonso CJ; Alevra M; Strauss S; Moser T; Jungmann R; Rizzoli SO; Opazo F
    Nanoscale; 2020 May; 12(18):10226-10239. PubMed ID: 32356544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
    Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
    Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation analysis of the SHOC2 gene in Noonan-like syndrome and in hematologic malignancies.
    Komatsuzaki S; Aoki Y; Niihori T; Okamoto N; Hennekam RC; Hopman S; Ohashi H; Mizuno S; Watanabe Y; Kamasaki H; Kondo I; Moriyama N; Kurosawa K; Kawame H; Okuyama R; Imaizumi M; Rikiishi T; Tsuchiya S; Kure S; Matsubara Y
    J Hum Genet; 2010 Dec; 55(12):801-9. PubMed ID: 20882035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stratifying fascin and cortactin function in invadopodium formation using inhibitory nanobodies and targeted subcellular delocalization.
    Van Audenhove I; Boucherie C; Pieters L; Zwaenepoel O; Vanloo B; Martens E; Verbrugge C; Hassanzadeh-Ghassabeh G; Vandekerckhove J; Cornelissen M; De Ganck A; Gettemans J
    FASEB J; 2014 Apr; 28(4):1805-18. PubMed ID: 24414419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-cell biopanning with a synthetic phage display library of nanobodies enabled the recovery of follicle-stimulating hormone receptor inhibitors.
    Crepin R; Veggiani G; Djender S; Beugnet A; Planeix F; Pichon C; Moutel S; Amigorena S; Perez F; Ghinea N; de Marco A
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1567-1572. PubMed ID: 29017919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity.
    Rodriguez-Viciana P; Oses-Prieto J; Burlingame A; Fried M; McCormick F
    Mol Cell; 2006 Apr; 22(2):217-30. PubMed ID: 16630891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.